Developer of a medical imaging technology designed to offer improved patient care. The company's technology utilizes cloud-based AI technology to visualize and quantify blood flow in the body using any MRI, enabling physicians to visualize and analyze blood flow inside the heart in 3D with automatic, interactive reporting. The company's next applications are in oncology, utilizing the same cloud-based AI technology.
Generating Revenue
Privately Held (backing)
Venture Capital-Backed
The company raised $30.06 million of Series B venture funding in a deal led by Temasek Holdings on November 3, 2017, putting the company's pre-money valuation at $52 million. GE Ventures, Varian Medical Systems, Northwell Ventures, NewYork-Presbyterian Ventures, Emergent Medical Partners, ORI Capital, DNA Capital and Fosun Capital Group also participated in the round.
Add a review